Skip to main content

Table 2 Relation between p27 immunoreactivity and clinicopathological variables of the studied cases

From: Assessment of survivin and p27 expression as potential prognostic markers in urothelial cell carcinoma of urinary bladder in Egyptian patients

Item (n.)

P27 immunopositivity

p-value

P27 expression score

p-value

Positive n (%)

Negative n (%)

 

Low score n (%)

High score n (%)

Mild chronic cystitis (20)

0

12 (100)

0.01

0

0

 < 0.001

Urothelial carcinoma (60)

26 (43.3)

34 (56.7)

 

19 (73)

7 (27)

 

Age

 < 60 years (21)

13 (62)

8 (38)

0.032

11 (84.6)

2 (15.4)

0.500

 ≥ 60 years (39)

13 (33.3)

26 (66.7)

 

8 (61.5)

5 (38.5)

 

Sex

Male (54)

24 (44.4)

30 (55.6)

0.472

18 (75)

6 (25)

0.526

Female (6)

2 (33.3)

4 (66.7)

 

2 (100)

0

 

Pattern

Papillary (33)

15 (45.5)

18 (54.5)

0.459

4 (26.7)

11 (64.7)

 < 0.001

Solid (27)

11 (40.7)

16 (59.3)

 

11 (100)

0

 

Grade

Low (23)

17 (74)

6 (26)

 < 0.001

6 (35.3)

11 (64.7)

0.002

High (37)

9 (24.3)

28 (75.7)

 

9 (100)

0

 

Stage

Superficial (30)

19 (63.3)

11 (36.7)

0.002

8 (42)

11 (58)

0.01

Deep (30)

7 (23.3)

23 (76.7)

 

7 (100)

0

 
  1. NMIBC Non-muscle invasive bladder cancer, MIBC Muscle-invasive bladder cancer, n Number, % Percentage